Every year, ASCO arrives with a theme. Most quietly disappear into the background by the end of the opening session, ...
ASCO 2026 marked an important transition in oncology. Rather than showcasing isolated advances, the meeting demonstrated how ...
Vietnam Investment Review on MSN
Gene Solutions SPOT MAS 10 real world data on 84,145 patients gains ASCO spotlight
SINGAPORE, July 7, 2026 /PRNewswire/ -- Gene Solutions, a biotechnology company advancing genomic solutions for cancer detection and precision oncology, today announced a major global milestone for ...
Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences ...
Though they are still primarily prescribed for weight loss and diabetes, researchers are looking at the effects of GLP-1s for a wide variety of conditions from substance abuse dis ...
Kura Oncology is positioning ziftomenib (KOMZIFTI) as a combination backbone in AML, not just a relapsed/refractory ...
Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted ...
Upcoming free, educational webinars from Xtalks will feature topics on biomarkers, clinical trials, commercialization and HEOR, emerging market, food ingredients and innovations, laboratory technology ...
The "Mad Money" host revisits a stock he spent years dismissing.
Globally recognized leader in early-phase oncology clinical development and experimental therapeuticsStrengthens strategic ...
Tech Park and Industrial Zones Authority (DSEZA), in collaboration with the Vietnamese Embassy in Germany, brought together investors in Berlin on July 6 to promote the central Vietnamese city as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results